In 1916, Douglas and Colebrook noted that blood coagulation was accelerated by the addition of trypsin. A year later, Heard reported that trypsin could actually coagulate oxalated blood, and ascribed the phenomenon to a hypothetical disturbance in the Ca and P content of the fibrinogen, induced by the enzyme. These two reports were apparently overlooked by workers in the field. In 1928, Waldschmidt-Leitz and his coworkers also reported that trypsin accelerated blood coagulation. They considered their experiments to prove that thrombin was a proteolytic enzyme either identical with or closely related to trypsin; that coagulation was due to the enzymic hydrolysis of fibrinogen to an insoluble modification; and that trypsin accelerated coagulation insofar as it hastened this hydrolysis. They found other proteolytic enzymes, including papain, to be inactive.
In addition to trypsin, papain was also found capable of initiating coagulation, but by a different mechanism. The latter is a true thrombin, insofar as it acts directly on fibrinogen to form an insoluble modification resembling fibrin. Trypsin, however, does not coagulate fibrinogen, but apparently reacts with plasma prothrombin to form the physiological coagulant thrombin.
Methods and Materials
We are indebted to the Mulford Biological Laboratories at Glenolden for the citrated horse blood used in most of the experiments. The crude trypsin was the Digestive Ferments Company's "Trypsin 1:110," and the papain was a powder supplied by Merck. Both preparations were quite acid, and the suspensions in salt solution had to be cautiously neutralized before using. The suspended solids in such neutralized preparations were found to be relatively inert and could be removed by centrifugation.
We are deeply indebted to Dr. John H. Northrop of The Rockefeller Institute for Medical Research at Princeton for a most generous supply of crystalline trypsin for use in these experiments. It is to be noted that the concentrations mentioned in the text are those of the dry powder; and this contains approximately 60 per cent MgSO4.
Preparation of Prothromb/n.--The precipitation of water-diluted plasma with acetic acid as described by Mellanby (1931) proved to be simple and to yield a more active product than the similar precipitation with CO2 described by Eagle (1935a) in ignorance of the former procedure.
Plasma was diluted with 15 volumes of cold (0-5 °) water, and N/1 acetic acid was added until the precipitate became visibly granular. Usually, an amount of acid corresponding to 1/20 the original plasma volume suflficed.
The centrifuged precipitate was dissolved in 0.85 per cent NaCl up to the original plasma volume, and neutralized cautiously with either N/1 Na2 CO8 or NaOH solution. The resultant opalescent solution contained fibrinogen, which could be removed by heating at 56 ° for 3-5 minutes, with little or no decrease in prothrombin activity of the solution (Eagle (1935a) ).
Alternatively, the prothrombin was purified by the MeUanby technic. The original acetic acid precipitate was suspended in water in a volume corresponding to 1/2 the original plasma volume, and this suspension then diluted with an equal volume of a 1/10 dilution of saturated Ca (OH)~ previously brought to pH 7.0 with CO2. After 10 minutes, the mixture was centrifuged and the supernatant fluid, containing a large proportion of the prothrombin and little or no fibrinogen, was rendered isotonic by the addition of 1/20 volume of 17 per cent NaC1.
Preparation of Fibrinogen.--Repeated precipitations (three to four) with 1.5 volumes of saturated NaCI yielded a satisfactory product which failed to coagulate on the addition of Ca and tissue extracts, but was promptly coagulated on the addition of thrombin. The final product was brought to a concentration of 0.9 per cent with respect to NaCI by proper dilution.
Quantitative Estimation of Thrombin Activity.--The time required for a given solution of thrombin to cause the coagulation of fibrinogen under standard conditions of temperature, volume, and salt concentration, was used as a criterion of its activity, and could be compared with the activity of other solutions by interpolation on a curve correlating coagulation time with thrombin concentration (Eagle (1935a)). 
The Coagulation of Blood or Plasma by Trypsin
A typical experiment which illustrates the fact that coagulation is observed only within a comparatively narrow optimum zone of trypsin concentration is given in Table I . That the clot results from the precipitation of the fibrinogen as a fibrillar gel resembling fibrin is clearly indicated by the following observations: (1) plasma from which the fibrinogen is removed by heating for 5 minutes at 56 °, or by half saturation with NaC1, can no longer be coagulated by the enzyme; (2) the supernatant fluid expressed from the clot contains no fibrinogen, as shown by heating to 56 °, or by half saturation with NaCI; moreover, it no longer clots on the addition of either Ca or thrombln in sufficient concentration to coagulate the original plasma; (3) the clot is microscopically indistinguishable from that which forms physiologically.
The participation of calcium in the coagulation of plasma by trypsin was rendered improbable by the fact that coagulation was observed in trypsin: plasma mixtures containing so much citrate and so little trypsin that even had the latter consisted solely of CaCl~, no coagulation would have been observed. Moreover, the coagulating activity of the trypsin was quantitatively unaffected by previous dialysis.
Definitive proof that the observed coagulation was due to the trypsin per se, rather than adventitious substances such as Ca, was furnished by the fact that crystalline trypsin (Northrop and Kunitz) also caused coagulation of citrated blood or plasma, and was approximately 20 to 50 times as active in this respect as the crude trypsin. It is true that the crystalline enzyme preparation contained MgS04: but the latter, in any concentration, failed to cause coagulation of citrated horse plasma; and if the trypsin was dialyzed against distilled water until it contained no demonstrable free SO,, its coagulating activity was found to have been quantitatively unaffected.
The Mechanism of the Trypsin Effect.--Physiological coagulation involves two consecutive reactions. In the first of these, a plasma factor (prothrombin) is activated by Ca and platelets (or tissue extracts) to form thrombin; subsequently, this thrombin reacts with fibrinogen to form fibrin. It becomes of interest to ascertain how trypsin causes coagulation: whether it replaces one or more of these physiological reagents, or whether the phenomenon is wholly unrelated to the physiological transformation of fibrinogen to fibrin. Trypsin was found to have no direct coagulative action on purified fibrinogen. In sufficient excess, the enzyme digested the protein, and rendered it incoagulable even by thrombin: but no clots were produced when trypsin in any concentration was mixed with fibrinogen (cf. Table IV ). Contrary to the thesis of Waldschmidt-Leitz and coworkers, trypsin is therefore not analogous to thrombin.
Instead, the coagulating action of trypsin was found to rest on the fact that it reacts with prothrombin to form thrombin; and this thrombin then acts on fibrinogen to form fibrin. If one adds varying amounts of trypsin to a solution of prothrombin, and tests the coagulating properties of the mixture at intervals by adding aliquot portions to purified fibrinogen, one obtains results similar to those illustrated in Fig. 1 disproportionate increase in the amount of thrombin formed. At a sharply defined optimum there is the rapid formation of a large amount of thrombin. This is usually between ½ and ] the mount formed from the same prothrombin by Ca and tissue extract; but in some experiments the two thrombins are of approximately the same activity. With an excess of the enzyme, no thrombin formation can
Protocol 1
Thrombin is rapidly destroyed by the concentrations of trypsin necessary for the activation of prothrombin (Fig. 2) .
To 1.6 cc. of horse thrombin (prothrombin + Ca + lung extract) were added 0.4 ce. of ~/10 phosphate buffers and varying amounts of trypsin. The thrombin activity of the mixtures was tested at intervals by adding aliquot portions to 0.4 ce. fibrinogen and noting the coagulation time. The curves given in Fig. 2 represent the amount of residual thrombin after 5 minutes. The results at pH 6.5, 6.2, 5.9, Fro. 2. Thrombin is rapidly destroyed by the concentrations of trypsin necessary for the activation of prothrombin. and 5.6 are not given, as they are practically identical with the curve at pH 6.8. The dotted curve in the figure represents the amount of thrombin formed from the same prothrombin in 15 minutes by varying amounts of trypsin: and it is apparent that at the effective concentrations, thrombin is being destroyed almost as fast as it is formed.
In this experiment, as in that of Protocol 2, the pK' of the phosphate buffer was arbitrarily taken as 6.8. The pH values given in the figures and tables are therefore in error to the extent that the pK' of the several buffer-salt mixtures deviates from 6.8 because of their varying ionic strength.
be demonstrated, because of the digestion of prothrombin, thrombin, or both. It is to be noted that the thrombin formed at the optimum trypsin concentration is eventually similarly digested, and is often no longer demonstrable after 1 or 2 hours.
The formation and destruction of thrombin proceed simultaneously (Protocol 1 and Fig. 2) ; and the amount of thrombin demonstrated at any one time is a resultant of the two processes. As is shown in Fig. 1 , Table III, optimum concentrations of trypsin, and explains the fact that the amount of thrombin elaborated by trypsin is usually only a fraction of that formed on the addition of Ca and tissue extract to the same prothrombin solution.
The quantitative relationships between the amount of prothrombin solution used, the amount of thrombin formed, and the optimum concentration of trypsin are illustrated in Fig. 3 . As is there shown, there is a linear relationship between all three factors. The more prothrombin used, the more thrombin is formed, and the greater is the amount of trypsin necessary to effect the transformation. Because of the progressive digestion of thrombin at the higher concen- * An aqueous extract of rabbit lung tissue, previously washed free of blood, minced, and kept frozen until needed. Such extracts contained no demonstrable prothrombin or fibrinogen. The tissue extract could be replaced by a washed platelet suspension, which yielded the same results: a marked acceleration of thrombin formation in the presence of Ca, but no effect on thrombin formation by trypsin.
trations of trypsin, the exact shape of the curves will vary according to the time interval allowed. Thus, if the experiment of Fig. 3 were terminated after 15 minutes instead of 90 minutes, each of the curves would be higher, and would be shifted to the right (less destruction of thrombin by the trypsin): but the relationships between prothrombin, thrombin, and trypsin there indicated would still hold.
The optimum concentration of trypsin is determined largely by the protein content of the prothrombin solution. The addition to the latter of inert serum, containing no demonstrable thrombln or prothrombin, causes a proportionate shift in the amount of trypsin necessary for thrombin formation. The important factor is apparently the amount of trypsin per unit protein; and the progressive shift in the optimum trypsin concentration as the amount of prothrombin solution is increased (Fig. 3) is an expression of this fact.
The reaction between trypsin and prothrombin is independent of the presence of either Ca, platelets, or tissue extractives. Prothrombin prepared from Berkefeld-fdtered plasma, and which contains neither Ca nor tissue extractive, is readily activated by trypsin; moreover, the rate of activation and the amount of thrombin formed are not affected by the addition of even large amounts of tissue extract (Table II) .
An attempt to determine the optimum pH for the trypsin-prothrombin reaction is summarized in Protocol 2 and Table III. As is there shown, the higher the concentration of trypsin, the more acid is the apparent pH optimum; and this dependence on the trypsin concentration is accentuated if the .trypsin-prothrombin mixture is allowed to incubate for some time before the thrombin content is determined. The discrepancy is explained by the data of Fig. 2 . Thrombin is rapidly destroyed only by the higher concentrations of trypsin; and this destruction proceeds more rapidly in the alkaline range than it does at pH 6.8 or 6.5, causing an acid shift in the apparent optimum pH for thrombin production. The experiment of Table III therefore offers no clue as to the true pH optimum for thrombin production by trypsin; but indicates instead how the amount of net free thrombin varies with pH, trypsin concentration, and time.
That the coagulant produced by the interaction of trypsin and solutions of prothrombin is actually thrombin would seem to require no proof. It is nevertheless of interest to note that if one adds trypsin V
Protocol 2
The effect of pH on the trypsin-prothrombin reaction (Table III) . To 1.6 cc. of horse prothrombin solution (heated at 56°C. for 5 minutes to remove fibrinogen) were added 0.4 cc. of ~/10 phosphate buffers and 0.4 cc. of varying concentrations of crystalline trypsin as indicated in Table III . At the intervals there shown, aliquot portions of each solution were withdrawn and tested for thrombin activity by adding varying quantities to a fixed amount of similarly buffered fibrinogen and noting the coagulation time (cf. page 545). In estimating the thrombin content of the solutions, it was necessary to take into consideration the fact that the coagulation time obtained with a given amount of thrombin varies with the pH. Accordingly, a series of reference curves was constructed, correlating the coagulation time with thrombin concentration at the various pH levels used in the actual experiment; and the thrombin content of a given solution was obtained by interpolating the observed coagulation time on the appropriate reference curve.
TABLE III

The Effect of pH on the Formation of Thrombin from Prothrombin by Trypsin
in less than optimum concentrations to some prothrombin, and obtains, e.g. a 20 per cent yield of coagulant; and if one then adds Ca and tissue extractive, the total amount of coagulant formed is exactly the same as would have been formed by the Ca and tissue factor alone. Conversely, trypsin added to formed Ca-thrombin (a prothrombin-Ca-tissue extract mixture) has no effect other than to digest the coagulant if added in excess.
Clearly, trypsin and the Ca-tissue (or Ca-platelet) system are mutually supplementary, and affect the same substrate, prothrombin, to form as end products coagulants which are qualitatively indistinguishable. As has already been shown, the fact that the amount
Protocol 3
The coagulation of blood in rivo by trypsin.
1. 10 cc. of a 5 per cent solution of crude trypsin were injected intravenously into a rabbit weighing approximately 2 kg. The animal died in convulsions in 2 minutes, and large clots were found in the great veins 2 minutes after death.
2. 1 cc. portions of a 5 per cent solution of crude trypsin were injected into a rabbit at 10 minute intervals. 11/~ minutes after the fourth injection it began to convulse, and was dead 1 minute later. On autopsy 6 minutes later the right ventricle and both auricles were found filled with a solid clot.
3. 10 cc. of 5 per cent trypsin were injected intravenously into a rabbit. 5 seconds later, the animal began to convulse, and died within 2 minutes. The heart, opened 3~ minutes after death, contained a solid clot in every chamber except the left ventricle, which was fibrillating. Blood obtained from the great veins would not clot, and no precipitate was obtained either on heating the plasma at 56°C. for 5 minutes, or on the addition of 1.5 volumes of saturated NaC1. of thrombin formed from prothrombin at the optimum trypsin concentration is usually less than that elaborated by the addition of Ca is due to the rapid digestion of the formed thrombin by the trypsin.
The implications of this analogy are discussed on page 557. Whether trypsin, as a proteolytic enzyme, hydrolyzes prothrombin to form thrombin, or whether trypsin combines with prothrombin to form a new enzyme, thrombin, must be left unanswered for the present (cf. page 557).
As is described in Protocol 3, trypsin injected intravenously into rabbits causes almost immediate death. Large blood clots are found in the heart and large vessels; the free fluid is non-coagulable, and contains no demonstrable fibrinogen. Trypsin thus seems to initiate blood coagulation in vivo as readily as it does in vitro. FIo. 4. Papain converts prothrombin to thrombin only because of its Ca content: but the enzyme as such coagulates fibrinogen. The prothrombin used in this experiment was the acetic acid precipitate heated at 56°C. to remove fibrinogen (of. page 544), and contained su/ficient platelet material to be activated to thrombin by the addition of Ca alone. The oxalated papain solution contained 0.016 M sodium oxalate, and was centrifuged free of the precipitated Ca oxalate. The citrated papain contained 0.15 • sodium citrate.
The Coagulation of Blood or Plasma by Papain
In view of the results obtained with trypsin, it became of interest to ascertain whether other proteolytic enzymes had a similar effect. Papain, the enzyme present in the juice of the papaw, was accordingly tested, and was found to be active. Unlike trypsin, however, papain 
• It" "1--"1"-I "~¢~ as such does not activate prothrombin to thrombin, but does act directly on fibrinogen to form a fibrillar gel resembling fibrin. As one repeatedly precipitates and redissolves fibrinogen, it becomes progressively less coagulable by either Ca -t-platelets or by trypsin, because of the rapid and eventually complete removal of prothrombin; but its coagulability by papain is unaffected (Table IV) . It should be pointed out that the crude enzyme powder contains large quantities of calcium, and accordingly activates prothrombin to thrombin. However, if the Ca is removed by the addition of oxalate or citrate, papain no longer activates prothrombin, but retains its coagulative action on fibrinogen quantitatively (Fig. 4) . The clots formed by the action of papain are relatively soft, particularly when high concentrations of the enzyme are used; and in that range one observes a rapid re-solution of the clot analogous to the slow fibrinolysis occasionally observed after physiological coagulation.
DISCUSSION
I. Crystalline trypsin has been found to activate prothrombin to thrombin. The available data offer no clue as to whether the prothrombin is merely hydrolyzed, or whether the enzyme actually combines with prothrombin to form a modified enzyme, thrombin. The minute amounts of trypsin which suffice are wholly compatible with a theory of stoichiometric combination. Thus, 0.003 cc. of a 0.04 per cent solution of crystalline trypsin activated 1 cc. of a prothrombin solution containing 0.04 per cent protein. The trypsin: protein ratio was approximately 1:300; but since the actual prothrombin in a so called prothrombin solution is probably a very small fraction of the total solids present, the trypsin: prothrombin ratio in this experiment may well have been 1:50, 1:5, or even I:I.
2. The terms cytozyme, thrombozyme, and thrombokinase which have been applied to the platelet (or tissue) factor by various investigators express their belief that this factor functions as an enzyme in the activation of prothrombin to thrombin. The only objective evidence hitherto presented in support of this hypothesis is (a) the minute amount of platelets or tissue extractive which suf~ces to produce a maximum yield of thrombin, and (b) the fact that further increase in the amount of platelets merely accelerates thrombin production and does not affect the quantity formed (Eagle (1935 a) ).
The present experiments show that trypsin has the same activating effect on prothrombin as the physiological system, Ca + platelets (or Ca + tissue extracts). It is difficult to conceive of so specific a phenomenon as the transformation of prothrombin to thrombin being effected by two wholly dissimilar mechanisms. We therefore suggest as a tentative working hypothesis that Ca -t-platelets together constitute a proteolytic enzyme analogous to trypsin, 1 which reacts with prothrombin to form thrombin. As in the case of trypsin, there is no experimental evidence which justifies a choice between the theory that the platelets combine with prothrombin to form thrombin, and the alternative possibility that the transformation merely involves enzymic hydrolysis.
We have been unable to demonstrate any proteolysis (formol titration) during the Ca-platelet-prothrombin reaction: but it is entirely possible that such proteolysis occurs and escapes detection because of the minute molecular concentration of actual prothrombin in the preparations used.
3. The effect of trypsin here described has several other important implications. Howell and Fuchs maintain that prothrombin is present in circulating blood as an inactive heparin-prothrombin compound; that platelets combine with heparin and thus release free prothrombin; and that this free prothrombin then reacts with Ca to form thrombin. ~ The present experiments clearly show that Ca is not necessarily an intrinsic part of thrombin, for trypsin reacts directly with prothrombin to form thrombin in its complete absence. Again, according to the theory of Howell and Fuchs, platelets or tissue extracts mobilize prothrombin from its hypothetical union with heparin, and should therefore increase the rate and degree of thrombin production, whether one uses Ca or trypsin as the activating agent. As is illustrated in Table II , however, tissue extracts have no demonstrable effect on the rate or degree of thrombin formation by t The postulated platelet enzyme is dearly not trypsin as such: for trypsin rapidly digests formed thrombin, while Ca and platdets have little or no effect.
2 According to Fuchs, platelets function both in the hypothetical mobilization of prothrombin, and in the subsequent reaction with calcium. trypsin; and similar results have been obtained on using platelets instead of tissue extracts. It would therefore seem that the latter reagents do not function physiologically by freeing prothrombin from a hypothetical union with heparin. It is significant in this connection that trypsin injected intravenously coagulates circulating blood as readily as it coagulates plasma in vitro; the prothrombin of circulating blood is apparently free and reactive. There are other reasons to doubt that heparin is of physiologic significance in preventing intravascular coagulation (Quick; Mellanby (1935 a); Eagle, in preparation); and taken in conjunction with the experiments cited, they render the heparin theory improbable.
By the same token, the fact that trypsin can cause intravascular coagulation, seems to invalidate the theory of Bordet that circulating blood contains, not prothrombin as such, but an inactive precursor which becomes reactive only on contact with some foreign surface, such as glass.
4. A second proteolytic enzyme, papain, was found to have no effect on prothrombin other than its digestion, but was found to act directly on fibrinogen to form a fibrillar gel resembling fibrin. If one considers this product to bear only a superficial resemblance to fibrin, then the phenomenon is of no significance as regards physiological coagulation; but if the clot formed by papain is identified as fibrin, it becomes probable that thrombin, like papain, is a proteolytic enzyme.
This was the theory originally proposed by Schmidt in 1872; and the present experiments indicate that it is still the most sarisfactory working hypothesis as to the mechanism of thrombin action (cf. Eagle (1935 b) ).
5. Experiments now in progress indicate that the coagulating activity of proteolytic enzymes offers an adequate and simple explanation for the well known but hitherto unexplained observations that certain bacteria and certain snake venoms can cause plasma to coagulate: and they suggest a new attack (leucocytic enzymes) on the mechanism of fibrin deposition at sites of inflammation.
6. It is to be noted that the recently discovered activation of chymo-trypsinogen by trypsin, with the formation of chymo-trypsin (Kunitz and Northrop), offers a complete analogy for the mechanism of physiological coagulation as here suggested:
Substrate
Activating proteolytic enzyme Product, a proteolytic enzyme
Chymo-trypsinogen -4-Trypsin ~ Chymo-trypsin fl rypsin a-platelets Ca-tissue extracts Snake venoms* acterial proteases* Prothrombin -IThrombin, a proteolytic enzyme analogous to papain and certain snake venoms* in that it converts fibrinogen to fibrin.
* To be discussed in following papers.
SUMMARY
Crude or crystalline trypsin in proper concentration causes the blood or plasma of human beings, dogs, rabbits, guinea pigs, and horses to coagulate. It does not dot the fibrinogen directly, but reacts with prothrombin to form thrombin. Since trypsin thus has the same effect as the physiological system Ca plus platelets (or Ca plus tissue extracts), it is suggested as a tentative working hypothesis that the latter system contains a proteolytic enzyme with a specific affinity for prothrombin. Other implications of this trypsin effect with respect to the mechanism of physiological coagulation are discussed in the text (pages 55?-558).
The proteolytic enzyme papain also coagulates blood. In this case the enzyme does not activate prothrombin, but acts directly on fibrinogen to form a fibrillar gel resembling fibrin. If one admits this dot to be fibrin, this constitutes strong evidence that thrombin, the physiological coagulant, is also a proteolytic enzyme with a spedfic action on fibrinogen. BIBLIOGRAPHY Bordet, J., Ann. Inst. Pasteur, 1920 , 34, 561. Douglas, S. R., and Colebrook, L., ~ncet, 1916 , 2, 180. Eagle, H., J. Gen. Physiol., 1935a , 18, 531. Eagle, H., J. Gen. Physiol., 1935b 
